Adverse effects of two rifampicin dosage regimens for the prevention of meningococcal infection.
D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D006801:Humans; D008589:Meningococcal Infections / Q000517:prevention & control*; D008722:Methods; D011897:Random Allocation; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects*
D012293:Rifampin